These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21506635)

  • 1. ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation.
    Lövgren Bengtsson K; Morein B; Osterhaus AD
    Expert Rev Vaccines; 2011 Apr; 10(4):401-3. PubMed ID: 21506635
    [No Abstract]   [Full Text] [Related]  

  • 2. Saponin-adjuvanted particulate vaccines for clinical use.
    Skene CD; Sutton P
    Methods; 2006 Sep; 40(1):53-9. PubMed ID: 16997713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori.
    Skene CD; Doidge C; Sutton P
    Vaccine; 2008 Jul; 26(31):3880-4. PubMed ID: 18547687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation by iscoms, immune stimulating complexes.
    Morein B; Bengtsson KL
    Methods; 1999 Sep; 19(1):94-102. PubMed ID: 10525444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations.
    Behboudi S; Morein B; Villacres-Eriksson M
    Cytokine; 1997 Sep; 9(9):682-7. PubMed ID: 9325017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant formulations for experimental vaccines.
    Stewart-Tull DE
    Methods Mol Med; 2003; 87():175-94. PubMed ID: 12958456
    [No Abstract]   [Full Text] [Related]  

  • 7. ISCOMs and ISCOMATRIX.
    Sun HX; Xie Y; Ye YP
    Vaccine; 2009 Jul; 27(33):4388-401. PubMed ID: 19450632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
    Rönnberg B; Fekadu M; Morein B
    Vaccine; 1995 Oct; 13(14):1375-82. PubMed ID: 8585296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global transcriptional response to ISCOM-Matrix adjuvant at the site of administration and in the draining lymph node early after intramuscular injection in pigs.
    Ahlberg V; Lövgren Bengtsson K; Wallgren P; Fossum C
    Dev Comp Immunol; 2012 Sep; 38(1):17-26. PubMed ID: 22426325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Vaccine Formulation Laboratory: a platform for access to adjuvants.
    Collin N; Dubois PM
    Vaccine; 2011 Jul; 29 Suppl 1():A37-9. PubMed ID: 21684427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal adjuvants: preparation and formulation with antigens.
    Haensler J
    Methods Mol Biol; 2010; 626():73-90. PubMed ID: 20099122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particulate delivery systems for animal vaccines.
    Scheerlinck JP; Greenwood DL
    Methods; 2006 Sep; 40(1):118-24. PubMed ID: 16997719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status and potential application of ISCOMs in veterinary medicine.
    Morein B; Hu KF; Abusugra I
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids.
    Behboudi S; Morein B; Villacres-Eriksson M
    Clin Exp Immunol; 1996 Jul; 105(1):26-30. PubMed ID: 8697631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro/nanoparticle adjuvants: preparation and formulation with antigens.
    Malyala P; Singh M
    Methods Mol Biol; 2010; 626():91-101. PubMed ID: 20099123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques.
    Koopman G; Bogers WM; van Gils M; Koornstra W; Barnett S; Morein B; Lehner T; Heeney JL
    J Med Virol; 2007 May; 79(5):474-82. PubMed ID: 17385685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The iscom structure as an immune-enhancing moiety: experience with viral systems.
    Claassen I; Osterhaus A
    Res Immunol; 1992 Jun; 143(5):531-41. PubMed ID: 1439134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adjuvants--essential components of new generation vaccines].
    Dzierzbicka K; Kołodziejczyk AM
    Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine.
    Aguila A; Donachie AM; Peyre M; McSharry CP; Sesardic D; Mowat AM
    Vaccine; 2006 Jun; 24(24):5201-10. PubMed ID: 16650917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.